AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
15min chapter
Activist Starboard Value Takes $1 Billion Stake in Pfizer
Bloomberg Businessweek
Pfizer's Pandemic Aftermath: Challenges and Innovations
This chapter explores Pfizer's struggles post-COVID, including declining vaccine demand and investor dissatisfaction with acquisitions. It highlights the complexities of pharmaceutical innovation and the pressure on executives to maintain growth amid market fluctuations. Additionally, the discussion touches on the role of activist investors and the challenges faced in developing new medications.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode